BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1405@pharmaconomics
DTSTAMP:20260707T021632Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:ADAG Phase 2 — muzastotug (estimated date)
DESCRIPTION:Phase 2 trial results for muzastotug in microsatellite stable colorectal cancer (MSS CRC) are due ~ Jan 1\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1818838/000110465926038858/tm2610619d1_6k.htm\n\nTrack it: https://pharmaconomics.com/e/1405
URL:https://pharmaconomics.com/e/1405
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ADAG catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR